about
Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcomeMeta-analysis of the prevalence of renal cancer detected by abdominal ultrasonography.Is there a human homologue to the murine proteolysis-inducing factor?Mass spectrometric detection of candidate protein biomarkers of cancer cachexia in human urine.The use of automated quantitative analysis to evaluate epithelial-to-mesenchymal transition associated proteins in clear cell renal cell carcinomaTissue quality assessment using a novel direct elasticity assessment device (the E-finger): a cadaveric study of prostatectomy dissection.Carbonic anhydrase 9 expression increases with vascular endothelial growth factor-targeted therapy and is predictive of outcome in metastatic clear cell renal cancer.Consultation audio-recording reduces long-term decision regret after prostate cancer treatment: A non-randomised comparative cohort study.A teratoid cyst containing nephrogenic tissue in a woman with a horseshoe kidney.mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma.A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.Cancer cachexia and fatigue.The molecular mechanisms of skeletal muscle wasting: implications for therapy.Pathophysiology of cancer cachexia: much more than host-tumour interaction?The dermcidin gene in cancer: role in cachexia, carcinogenesis and tumour cell survival.Reduced Contractility and Motility of Prostatic Cancer-Associated Fibroblasts after Inhibition of Heat Shock Protein 90Small bowel injury after suprapubic catheter insertion presenting 3 years after initial insertion.Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies.What can molecular pathology contribute to the management of renal cell carcinoma?Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study.Midterm oncological outcome and clinicopathological characteristics of anterior prostate cancers treated by endoscopic extraperitoneal radical prostatectomy.Elasticity as a biomarker for prostate cancer: a systematic review.Five-year oncological outcomes of endoscopic extraperitoneal radical prostatectomy (EERPE) for prostate cancer: results from a medium-volume UK centre.Analysis of the pentafecta learning curve for laparoscopic radical prostatectomy.Matched pair analysis of laparoscopic versus open radical nephrectomy for the treatment of T3 renal cell carcinoma.Translational research will fail without surgical leadership: SCOTRRCC a successful surgeon-led Nationwide translational research infrastructure in renal cancer.Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer.Utilizing mRNA extracted from small, archival formalin-fixed paraffin-embedded prostate samples for translational research: assessment of the effect of increasing sample age and storage temperature.The role of cytoreductive surgery in the era of targeted agents.Improving outcomes in high-risk, nonmetastatic renal cancer: new data and ongoing trials.Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?Current Status of Focal Cryoablation for Small Renal Masses.Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study.Proteolysis-inducing factor core peptide mediates dermcidin-induced proliferation of hepatic cells through multiple signalling networks.DNA strand breaks and hypoxia response inhibition mediate the radiosensitisation effect of nitric oxide donors on prostate cancer under varying oxygen conditions.Surgical service centralisation in Australia versus choice and quality of life for rural patients.NO-sulindac inhibits the hypoxia response of PC-3 prostate cancer cells via the Akt signalling pathway.The continuing medical education activities and attitudes of Australian doctors working in different clinical specialties and practice locations.Dermcidin expression confers a survival advantage in prostate cancer cells subjected to oxidative stress or hypoxia.
P50
Q28486028-BBCDF3E8-6A71-4FA4-92C2-EDDE9883E1EAQ30234820-70B47C22-6E0C-4C1C-A1FE-E722C8E1F628Q33296960-3C5BC5CC-761E-49C7-914E-1BD5A4FB7CB4Q33536479-B7A3615B-6F6C-4B31-927A-CA770B49009AQ34171089-27A8D9D4-2D4A-4AFC-B1DD-AEADF1E27E5FQ35407493-01053B73-DFC3-4DD8-AF75-EC68FFD003FBQ35540063-E70FE654-3984-4094-9AE0-400A84962318Q35552091-D1E9A5A6-4F43-45DC-B5F2-798AD803BC2CQ35589075-4C04B0EB-94C2-4822-95DC-594C23D2A194Q36075298-AE1857E9-32C0-433D-BE33-CCA4ACB082ABQ36082104-285FC798-A304-4EB3-A7FC-25687F279BEBQ36239773-8651D8EC-42CD-4DA4-B408-2F141E7CF622Q36475230-9B828602-1BF2-4035-905B-7D5DE8C6C828Q36607060-99E7DEE7-AB27-48C0-BA85-4B3014E1AEC4Q36824333-11F82357-8920-4FB6-80EF-381E356DF94EQ37135101-4DD7DC44-B728-418B-858C-477123DDE809Q37293806-5291CB23-6462-4A5C-B446-EF0C18FA00C0Q37391908-01437B63-5D05-446A-83F6-1857D5039776Q37418080-A539E089-D570-4C4D-8A3D-600712D9483AQ37864528-C1E08817-982D-44C6-B327-F3204061D0EEQ38045642-2A659163-2FCA-4033-9038-C3B96EF13C68Q38113950-CC411F8C-43C6-4B36-9366-33E7D8B99F4DQ38125764-030AD069-59CB-4846-9392-875BDA56033DQ38131793-587481D6-0154-460D-A62C-84A23C3E9D9FQ38170269-2FA6072C-5BCE-4307-BF3F-D3F8C7999456Q38197539-1618A0CF-EC31-408C-A7F2-B398CDE07CA1Q38390224-92952685-C358-442B-9803-4BA5EEBA276BQ38394251-7F4ADA5C-1EA1-4794-B9DF-291EA3D9E26EQ38411140-CF5F626A-BB59-436F-984C-D7005882636FQ38527963-6AD3F2D9-EA15-4109-9013-1D1F88DBBA52Q38648762-AD20E316-0445-4A9A-8710-1DD223F48D1EQ38655000-16C645B4-FE90-4495-8402-2A965B4254B9Q38689855-0405B0D5-81E6-411A-B70E-C981B6247455Q38761275-7600A051-A4FA-4BA7-B04B-0161E231995BQ39530160-0130A929-A90A-42C3-9CB0-F2FEB1AC5796Q39648965-63F3206B-0417-4C78-87B8-47A7CF59B163Q39764716-D1FD0B6B-C4B0-4532-AE2C-9F4F4DD6D78CQ39928723-CEF28818-19F1-44B1-B1F9-394186E0C9B7Q40004197-F0591F5D-05BA-4229-8F5F-C17F95E5356CQ40108079-FEBD2D73-7BE9-44F7-BF9B-C52C93223F1F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Grant D. Stewart
@ast
Grant D. Stewart
@en
Grant D. Stewart
@es
Grant D. Stewart
@nl
Grant D. Stewart
@sl
type
label
Grant D. Stewart
@ast
Grant D. Stewart
@en
Grant D. Stewart
@es
Grant D. Stewart
@nl
Grant D. Stewart
@sl
prefLabel
Grant D. Stewart
@ast
Grant D. Stewart
@en
Grant D. Stewart
@es
Grant D. Stewart
@nl
Grant D. Stewart
@sl
P106
P1153
56241930600
P21
P31
P496
0000-0003-3188-9140